XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · IEX Real-Time Price · USD
2.590
+0.020 (0.78%)
Jul 18, 2024, 3:02 PM EDT - Market open

XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of $13.25 million as of July 18, 2024. Its market cap has increased by 145.33% in one year.

Market Cap
13.25M
Enterprise Value
11.41M
1-Year Change
145.33%
Ranking
Category
Stock Price
$2.59

Market Cap Chart

Since November 18, 2008, XTL Biopharmaceuticals's market cap has increased from $800.00K to $13.25M, an increase of 1,555.95%. That is a compound annual growth rate of 19.62%.

History

DateMarket Cap% Change
Jul 16, 202414.60M165.45%
Dec 29, 20235.50M-16.67%
Dec 30, 20226.60M-53.52%
Dec 31, 202114.20M-8.97%
Dec 31, 202015.60M122.86%
Dec 31, 20197.00M-21.35%
Dec 31, 20188.90M41.27%
Dec 29, 20176.30M270.59%
Dec 30, 20161.70M-56.41%
Dec 31, 20153.90M-15.22%
Dec 31, 20144.60M-31.34%
Dec 31, 20136.70M-55.63%
Dec 31, 201215.10M106.85%
Dec 30, 20117.30M160.71%
Dec 31, 20102.80M366.67%
Dec 31, 2009600.00K100.00%
Dec 31, 2008300.00K-62.50%
View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Avalo Therapeutics 13.42M
NEXGEL 13.14M
Kiora Pharmaceuticals 12.99M
Senti Biosciences 12.97M
Purple Biotech 12.84M
Mustang Bio 12.53M
Monopar Therapeutics 12.47M
RedHill Biopharma 12.43M
Market Cap Rankings